Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advax-adjuvanted low-dose seasonal influenza vaccine versus standard-dose vaccine
ACTRN12607000599471Phase 2Completed
- Sponsor
- Vaxine
- Start
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of ADVAX and trivalent inactivated influenza vaccine in seasonal influenza (2 arms), sponsored by Vaxine. Primary endpoints: Incidence of adverse events and Seroconversion and seroprotection against influenza. Started Jul 2007; status: completed.
02
Drugs
ADVAXtrivalent inactivated influenza vaccine
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on ACTRN12607000599471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000599471.